ROLE OF ANTILEUKOTRIENE DRUGS IN ACHIEVEMENT OF BRONCHIAL ASTHMA CONTROL
Bronchial asthma (BA) is a common chronic disease heterogeneous in nature and variable in its course. Heterogeneity in asthma is manifested in relation to the age of the onset, triggers, pattern of inflammation, severity of clinical manifestations and response to therapy. Cysteinyl leukotrienes play...
| Published in: | Медицинский совет |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-11-01
|
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2031 |
| Summary: | Bronchial asthma (BA) is a common chronic disease heterogeneous in nature and variable in its course. Heterogeneity in asthma is manifested in relation to the age of the onset, triggers, pattern of inflammation, severity of clinical manifestations and response to therapy. Cysteinyl leukotrienes play an important role in the pathogenesis of asthma and allergic rhinitis (AR), therefore, antagonists of leukotriene receptors approved themselves as effective drugs in controlling asthma therapies, particularly for some phenotypes. This review article is devoted to the modern role of Montelukast in asthma treatment. |
|---|---|
| ISSN: | 2079-701X 2658-5790 |